Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank50
3Y CAGR-34.5%
5Y CAGR-11.6%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
-34.5%/yr
vs -8.1%/yr prior
5Y CAGR
-11.6%/yr
Recent deceleration
Acceleration
-26.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$2.40M-50.9%
2024$4.88M-46.5%
2023$9.12M+6.7%
2022$8.54M+670.5%
2021$1.11M-75.0%
2020$4.44M-47.1%
2019$8.39M-29.8%
2018$11.97M+149.9%
2017$4.79M+265.0%
2016$1.31M-